Penumbra, Inc. PEN
NYSE · United States · Health Technology
$318.34-0.52 (-0.16%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | 0.88 | 1.16 | -24.3% | $390.05M | +0.1% | +0.3%$320.13→$321.19 |
| Q1 2026 | 2026-05-06 | 0.82 | 1.11 | -26.1% | — | — | +0.2%$323.86→$324.65 |
| Q4 2025 | 2026-02-25 | 1.18 | 1.12 | +5.4% | — | — | +0.7%$339.59→$341.94 |
| Q3 2025 | 2025-11-05 | 0.97 | 0.90 | +7.8% | — | — | +12.6%$235.08→$264.61 |
| Q4 2024 | 2025-02-18 | 0.97 | 0.89 | +9.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.